Page last updated: 2024-11-07

2-acetylaminofluorene and Carcinoma, Basal Cell

2-acetylaminofluorene has been researched along with Carcinoma, Basal Cell in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elejalde, BR1

Other Studies

1 other study available for 2-acetylaminofluorene and Carcinoma, Basal Cell

ArticleYear
In-vitro transformation of cells from patients with naevoid basal-cell-carcinoma syndrome.
    Lancet (London, England), 1976, Nov-27, Volume: 2, Issue:7996

    Topics: 2-Acetylaminofluorene; Adult; Carcinoma, Basal Cell; Cell Transformation, Neoplastic; Child; Humans;

1976